Skip to main content
Log in

CCN2 YAPs at cancer

  • Research Article
  • Published:
Journal of Cell Communication and Signaling Aims and scope

Abstract

The YAP transcription coactivator has been implicated as an oncogene and is amplified in human cancers. Previously, it has been shown that CCN2 (connective tissue growth factor, CTGF) is a target of the tumor promoting YAP and its transcription factor target TEAD. A recent report in Genes and Development by Zhao and colleagues (Genes Dev 22:1962–1971 2008) has extended these initial observations to show that CCN2 plays an important role in the growth-promoting function of YAP. These data confirm the role of CCN2 as a key oncogenic mediator. This report briefly summarizes these findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew Leask.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leask, A. CCN2 YAPs at cancer. J. Cell Commun. Signal. 2, 47–48 (2008). https://doi.org/10.1007/s12079-008-0027-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12079-008-0027-1

Keywords

Navigation